BATH & BODY WORKS INC (BBWI) Forecast, Price Target & Analyst Ratings
NYSE:BBWI • US0708301041
20.8 USD
-1.49 (-6.68%)
At close: Mar 6, 2026
20.8 USD
0 (0%)
After Hours: 3/6/2026, 8:04:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BATH & BODY WORKS INC (BBWI).
Forecast Snapshot
Consensus Price Target
$25.68
+ 23.46% Upside
Next Earnings Forecast
Release DateMay 19, 2026
PeriodQ1 / 2027
EPS Estimate$0.30
Revenue Estimate1.363B
ChartMill Buy Consensus
74.29%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$25.68
Upside
+ 23.46%
From current price of $20.80 to mean target of $25.68, Based on 21 analyst forecasts
Low
$17.17
Median
$23.46
High
$57.87
Price Target Revisions
1 Month
5.22%
3 Months
-30.47%
Price Target Summary
21 analysts have analysed BBWI and the average price target is 25.68 USD. This implies a price increase of 23.46% is expected in the next year compared to the current price of 20.8.
The average price target has been revised downward by 30.47% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
74.29%
BBWI was analyzed by 21 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about BBWI.
In the previous month the buy percentage consensus was at a similar level.
BBWI was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-03-05 | Telsey Advisory Group | Maintains | Market Perform -> Market Perform |
| 2026-03-04 | Telsey Advisory Group | Maintains | Market Perform -> Market Perform |
| 2026-03-02 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-27 | Telsey Advisory Group | Maintains | Market Perform -> Market Perform |
| 2026-02-23 | UBS | Maintains | Neutral -> Neutral |
| 2026-02-17 | Citigroup | Downgrade | Buy -> Neutral |
| 2026-01-08 | UBS | Maintains | Neutral -> Neutral |
| 2026-01-06 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-10 | Guggenheim | Initiate | Neutral |
| 2025-11-21 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-21 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-21 | Telsey Advisory Group | Downgrade | Outperform -> Market Perform |
| 2025-11-21 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-21 | Baird | Downgrade | Outperform -> Neutral |
| 2025-11-21 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2025-11-21 | B of A Securities | Maintains | Buy -> Buy |
| 2025-11-21 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-11-21 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-20 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2025-11-20 | B of A Securities | Maintains | Buy -> Buy |
| 2025-11-13 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2025-11-12 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2025-11-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-27 | Wells Fargo | Maintains | Overweight -> Overweight |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 19, 2026
PeriodQ1 / 2027
EPS Estimate$0.30
Revenue Estimate1.363B
Revenue Q2Q-4.28%
EPS Q2Q-38.82%
Number of Analysts14
Next Earnings Revisions
Revenue (1 Month)
0.23%
Revenue (3 Months)
-1.11%
EPS (1 Month)
0.25%
EPS (3 Months)
-6.78%
Next Earnings Summary
BBWI is expected to report earnings on 5/19/2026. The consensus EPS estimate for the next earnings is 0.3 USD and the consensus revenue estimate is 1.36B USD.
The next earnings revenue estimate has been revised downward by 1.11% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.56B -4.09% | 7.429B -1.73% | 7.307B -1.64% | 7.285B -0.30% | 7.142B -1.96% | 7.344B 2.83% | 7.67B 4.44% | 7.904B 3.05% | 8.159B 3.23% | 8.424B 3.25% | 8.693B 3.19% | 8.972B 3.21% | |
| EBITDA YoY % growth | 1.597B -32.67% | 1.554B -2.69% | 1.548B -0.39% | 1.338B -13.57% | 1.253B -6.35% | 1.271B 1.44% | 1.495B 17.62% | 1.596B 6.76% | 1.673B 4.82% | 1.735B 3.71% | 1.799B 3.69% | 1.866B 3.72% | |
| EBIT YoY % growth | 1.376B -31.51% | 1.285B -6.61% | 1.266B -1.48% | 1.085B -14.30% | 957.26M -11.77% | 1.003B 4.78% | 1.242B 23.83% | 1.336B 7.57% | 1.42B 6.29% | 1.474B 3.80% | 1.53B 3.80% | 1.588B 3.79% | |
| Operating Margin | 18.20% | 17.30% | 17.33% | 14.89% | 13.40% | 13.66% | 16.19% | 16.90% | 17.40% | 17.50% | 17.60% | 17.70% | |
| EPS YoY % growth | 3.42 -41.14% | 3.27 -4.39% | 3.33 1.83% | 2.96 -53.15% | 2.62 67.88% | 2.84 8.34% | 3.96 39.49% | 4.50 13.66% | 5.00 11.11% | 5.52 10.41% | 6.14 11.28% | 6.85 11.63% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.30 -38.82% | 0.21 -42.03% | 0.30 -14.20% | 1.82 418.98% | 0.32 5.48% | 0.18 -14.41% | 0.40 32.47% | 1.75 -3.42% |
| Revenue Q2Q % growth | 1.363B -4.28% | 1.506B -2.78% | 1.591B -0.19% | 2.648B 66.12% | 1.393B 2.20% | 1.539B 2.19% | 1.626B 2.20% | 2.629B -0.72% |
| EBITDA Q2Q % growth | 200.95M -26.39% | 182.61M -35.93% | 206.46M -41.35% | 575.96M -7.11% | 214.61M 6.80% | 179.52M -1.69% | 230.52M 11.65% | 597.11M 3.67% |
| EBIT Q2Q % growth | 139.83M -33.10% | 118.27M -24.67% | 145.12M -9.86% | 543.74M -0.25% | 149.33M 6.79% | 114.24M -3.41% | 166.26M 14.57% | 542.64M -0.20% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
36.39%
EPS Next 5 Year
26.22%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
1.73%
Revenue Next 5 Year
2.29%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-0.34%
EBIT Next 5 Year
4.45%
BATH & BODY WORKS INC / BBWI Forecast FAQ
What is the average price target for BATH & BODY WORKS INC (BBWI) stock?
21 analysts have analysed BBWI and the average price target is 25.68 USD. This implies a price increase of 23.46% is expected in the next year compared to the current price of 20.8.
What is the next earnings date for BBWI stock?
BATH & BODY WORKS INC (BBWI) will report earnings on 2026-05-19.
What are the consensus estimates for BATH & BODY WORKS INC (BBWI) next earnings?
The consensus EPS estimate for the next earnings of BATH & BODY WORKS INC (BBWI) is 0.3 USD and the consensus revenue estimate is 1.36B USD.
How many analysts have analysed BATH & BODY WORKS INC (BBWI)?
The number of analysts covering BATH & BODY WORKS INC (BBWI) is 21.